Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5587369 | Diabetes Research and Clinical Practice | 2017 | 33 Pages |
Abstract
Chronic AP administration significantly improved impaired glucose tolerance in high-normal and borderline subjects. Larger and/or longer-term scale human studies are required to confirm the potential glucose homeostasis of AP.
Keywords
HbA1cAPCLDL-CHOMA-IRT2DMALTHDL-CIFGGLP-1NGTγ-GTPIGTDPP-4PAI-1OGTTIL-6LPSApple procyanidinsFPGγ-glutamyl transpeptidaseOral glucose tolerance testASTAspartate aminotransferaseAlanine aminotransferaseALPAlkaline phosphataseimpaired glucose toleranceImpaired fasting glycaemiahomeostasis model assessment of insulin resistanceinterleukin-6Cardiovascular diseasesnormal glucose tolerancetriglyceridetumour necrosis factor-alphaType 2 diabetes mellitusDipeptidyl peptidase-4CVDbody mass indexBMITNF-αFasting plasma glucoselactate dehydrogenaseLDHhigh-density lipoprotein cholesterollipopolysaccharidePlasminogen activator inhibitor-1haemoglobin A1cApple polyphenolstotal cholesterolLow-density lipoprotein cholesterol
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Toshihiko Shoji, Mitsuhiro Yamada, Tomisato Miura, Kazuaki Nagashima, Kasane Ogura, Nobuya Inagaki, Mari Maeda-Yamamoto,